APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bioconjugation Service

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Bioconjugation Service Industry Growth and Trends Forecast to 2032

15 April 2026113 pages

Choose your research edition.

Industry ResearchBioconjugation Service Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Bioconjugation Service Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Bioconjugation Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bioconjugation Service Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Bioconjugation Service Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

According to APO Research, the global Bioconjugation Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Bioconjugation Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Bioconjugation Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bioconjugation Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Bioconjugation Service market include AxisPharm, CellMosaic, Bio-Synthesis, GBI, Lonza, NJ Bio, WuXi Biologics, Creative Biolabs and Biosynth, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Bioconjugation Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Bioconjugation Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Bioconjugation Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Bioconjugation Service.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Bioconjugation Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Bioconjugation Service Market by Company

AxisPharm

CellMosaic

Bio-Synthesis

GBI

Lonza

NJ Bio

WuXi Biologics

Creative Biolabs

Biosynth

Antibody Solutions

CheMatech

Thermo Fisher Scientific Inc

BOC Sciences

GTP Bioways

LifeSynth Solutions

iQ Biosciences

Macrocyclics

piramal pharma solutions

Bioconjugation Service Segment by Type

Protein Bioconjugation

Antibody Bioconjugation

Peptide Bioconjugation

Others

Bioconjugation Service Segment by Application

Pharmaceutical

Diagnostics

Biotechnology Research

Bioconjugation Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bioconjugation Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bioconjugation Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bioconjugation Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Bioconjugation Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Bioconjugation Service Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Bioconjugation Service Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Bioconjugation Service Market Share by Region (2021-2026) Table 4. Global Bioconjugation Service Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Bioconjugation Service Market Share by Region (2027-2032) Table 6. Global Bioconjugation Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Bioconjugation Service Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Bioconjugation Service Market Size Share by Type (2021-2026) Table 9. Global Bioconjugation Service Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Bioconjugation Service Market Size Share Forecasted by Type (2027-2032) Table 11. North America Bioconjugation Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Bioconjugation Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Bioconjugation Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Bioconjugation Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Bioconjugation Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Bioconjugation Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Bioconjugation Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Bioconjugation Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Bioconjugation Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Bioconjugation Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Bioconjugation Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Bioconjugation Service Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Bioconjugation Service Market Size Share by Application (2021-2026) Table 24. Global Bioconjugation Service Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Bioconjugation Service Market Size Share Forecasted by Application (2027-2032) Table 26. North America Bioconjugation Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Bioconjugation Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Bioconjugation Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Bioconjugation Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Bioconjugation Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Bioconjugation Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Bioconjugation Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Bioconjugation Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Bioconjugation Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Bioconjugation Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Bioconjugation Service Industry Trends Table 37. Bioconjugation Service Industry Drivers Table 38. Bioconjugation Service Industry Opportunities and Challenges Table 39. Bioconjugation Service Industry Restraints Table 40. Global Bioconjugation Service Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Bioconjugation Service Revenue Market Share by Company (2021-2026) Table 42. Global Bioconjugation Service Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Bioconjugation Service Key Company Headquarters & Area Served Table 44. Global Bioconjugation Service Company, Product Type & Application Table 45. Global Bioconjugation Service Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Bioconjugation Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. AxisPharm Company Information Table 49. AxisPharm Business Overview Table 50. AxisPharm Bioconjugation Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. AxisPharm Bioconjugation Service Product Portfolio Table 52. AxisPharm Recent Development Table 53. CellMosaic Company Information Table 54. CellMosaic Business Overview Table 55. CellMosaic Bioconjugation Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. CellMosaic Bioconjugation Service Product Portfolio Table 57. CellMosaic Recent Development Table 58. Bio-Synthesis Company Information Table 59. Bio-Synthesis Business Overview Table 60. Bio-Synthesis Bioconjugation Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Bio-Synthesis Bioconjugation Service Product Portfolio Table 62. Bio-Synthesis Recent Development Table 63. GBI Company Information Table 64. GBI Business Overview Table 65. GBI Bioconjugation Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. GBI Bioconjugation Service Product Portfolio Table 67. GBI Recent Development Table 68. Lonza Company Information Table 69. Lonza Business Overview Table 70. Lonza Bioconjugation Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Lonza Bioconjugation Service Product Portfolio Table 72. Lonza Recent Development Table 73. NJ Bio Company Information Table 74. NJ Bio Business Overview Table 75. NJ Bio Bioconjugation Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. NJ Bio Bioconjugation Service Product Portfolio Table 77. NJ Bio Recent Development Table 78. WuXi Biologics Company Information Table 79. WuXi Biologics Business Overview Table 80. WuXi Biologics Bioconjugation Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. WuXi Biologics Bioconjugation Service Product Portfolio Table 82. WuXi Biologics Recent Development Table 83. Creative Biolabs Company Information Table 84. Creative Biolabs Business Overview Table 85. Creative Biolabs Bioconjugation Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Creative Biolabs Bioconjugation Service Product Portfolio Table 87. Creative Biolabs Recent Development Table 88. Biosynth Company Information Table 89. Biosynth Business Overview Table 90. Biosynth Bioconjugation Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Biosynth Bioconjugation Service Product Portfolio Table 92. Biosynth Recent Development Table 93. Antibody Solutions Company Information Table 94. Antibody Solutions Business Overview Table 95. Antibody Solutions Bioconjugation Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Antibody Solutions Bioconjugation Service Product Portfolio Table 97. Antibody Solutions Recent Development Table 98. CheMatech Company Information Table 99. CheMatech Business Overview Table 100. CheMatech Bioconjugation Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. CheMatech Bioconjugation Service Product Portfolio Table 102. CheMatech Recent Development Table 103. Thermo Fisher Scientific Inc Company Information Table 104. Thermo Fisher Scientific Inc Business Overview Table 105. Thermo Fisher Scientific Inc Bioconjugation Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Thermo Fisher Scientific Inc Bioconjugation Service Product Portfolio Table 107. Thermo Fisher Scientific Inc Recent Development Table 108. BOC Sciences Company Information Table 109. BOC Sciences Business Overview Table 110. BOC Sciences Bioconjugation Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. BOC Sciences Bioconjugation Service Product Portfolio Table 112. BOC Sciences Recent Development Table 113. GTP Bioways Company Information Table 114. GTP Bioways Business Overview Table 115. GTP Bioways Bioconjugation Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. GTP Bioways Bioconjugation Service Product Portfolio Table 117. GTP Bioways Recent Development Table 118. LifeSynth Solutions Company Information Table 119. LifeSynth Solutions Business Overview Table 120. LifeSynth Solutions Bioconjugation Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. LifeSynth Solutions Bioconjugation Service Product Portfolio Table 122. LifeSynth Solutions Recent Development Table 123. iQ Biosciences Company Information Table 124. iQ Biosciences Business Overview Table 125. iQ Biosciences Bioconjugation Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. iQ Biosciences Bioconjugation Service Product Portfolio Table 127. iQ Biosciences Recent Development Table 128. Macrocyclics Company Information Table 129. Macrocyclics Business Overview Table 130. Macrocyclics Bioconjugation Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Macrocyclics Bioconjugation Service Product Portfolio Table 132. Macrocyclics Recent Development Table 133. piramal pharma solutions Company Information Table 134. piramal pharma solutions Business Overview Table 135. piramal pharma solutions Bioconjugation Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. piramal pharma solutions Bioconjugation Service Product Portfolio Table 137. piramal pharma solutions Recent Development Table 138. North America Bioconjugation Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America Bioconjugation Service Market Size by Country (2021-2026) & (US$ Million) Table 140. North America Bioconjugation Service Market Share by Country (2021-2026) Table 141. North America Bioconjugation Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America Bioconjugation Service Market Share Forecast by Country (2027-2032) Table 143. Europe Bioconjugation Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Europe Bioconjugation Service Market Size by Country (2021-2026) & (US$ Million) Table 145. Europe Bioconjugation Service Market Share by Country (2021-2026) Table 146. Europe Bioconjugation Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Europe Bioconjugation Service Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Bioconjugation Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Bioconjugation Service Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Bioconjugation Service Market Share by Country (2021-2026) Table 151. Asia-Pacific Bioconjugation Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Bioconjugation Service Market Share Forecast by Country (2027-2032) Table 153. Latin America Bioconjugation Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Bioconjugation Service Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Bioconjugation Service Market Share by Country (2021-2026) Table 156. Latin America Bioconjugation Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Bioconjugation Service Market Share Forecast by Country (2027-2032) Table 158. Middle East & Africa Bioconjugation Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Middle East & Africa Bioconjugation Service Market Size by Country (2021-2026) & (US$ Million) Table 160. Middle East & Africa Bioconjugation Service Market Share by Country (2021-2026) Table 161. Middle East & Africa Bioconjugation Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Middle East & Africa Bioconjugation Service Market Share Forecast by Country (2027-2032) Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Bioconjugation Service Product Image Figure 3. Global Bioconjugation Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Bioconjugation Service Market Size (2021-2032) & (US$ Million) Figure 5. Global Bioconjugation Service Market Share by Region: 2025 VS 2032 Figure 6. Global Bioconjugation Service Market Share by Region (2021-2032) Figure 7. North America Bioconjugation Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Bioconjugation Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Bioconjugation Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Bioconjugation Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Bioconjugation Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Protein Bioconjugation Image Figure 13. Global Protein Bioconjugation Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Antibody Bioconjugation Image Figure 15. Global Antibody Bioconjugation Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Peptide Bioconjugation Image Figure 17. Global Peptide Bioconjugation Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Others Image Figure 19. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Bioconjugation Service Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Bioconjugation Service Market Share by Type 2025 VS 2032 Figure 22. North America Bioconjugation Service Market Size Share by Type (2021-2032) Figure 23. Europe Bioconjugation Service Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Bioconjugation Service Market Size Share by Type (2021-2032) Figure 25. Latin America Bioconjugation Service Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Bioconjugation Service Market Size Share by Type (2021-2032) Figure 27. Pharmaceutical Image Figure 28. Global Pharmaceutical Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Diagnostics Image Figure 30. Global Diagnostics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Biotechnology Research Image Figure 32. Global Biotechnology Research Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Bioconjugation Service Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Bioconjugation Service Market Share by Application 2025 VS 2032 Figure 35. North America Bioconjugation Service Market Size Share by Application (2021-2032) Figure 36. Europe Bioconjugation Service Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Bioconjugation Service Market Size Share by Application (2021-2032) Figure 38. Latin America Bioconjugation Service Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Bioconjugation Service Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Bioconjugation Service Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Bioconjugation Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Bioconjugation Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Bioconjugation Service Market Share by Country (2021-2032) Figure 45. Europe Bioconjugation Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Bioconjugation Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Bioconjugation Service Market Share by Country (2021-2032) Figure 48. Asia-Pacific Bioconjugation Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Bioconjugation Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Bioconjugation Service Market Share by Country (2021-2032) Figure 51. Latin America Bioconjugation Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Bioconjugation Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Bioconjugation Service Market Share by Country (2021-2032) Figure 54. Middle East & Africa Bioconjugation Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Bioconjugation Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Bioconjugation Service Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Protein Bioconjugation
  • Antibody Bioconjugation
  • Peptide Bioconjugation
  • Others
Applications
  • Pharmaceutical
  • Diagnostics
  • Biotechnology Research
Companies covered
  • AxisPharm
  • CellMosaic
  • Bio-Synthesis
  • GBI
  • Lonza
  • NJ Bio
  • WuXi Biologics
  • Creative Biolabs
  • Biosynth
  • Antibody Solutions
  • CheMatech
  • Thermo Fisher Scientific Inc
  • BOC Sciences
  • GTP Bioways
  • LifeSynth Solutions
  • iQ Biosciences
  • Macrocyclics
  • piramal pharma solutions

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Bioconjugation Service Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Bioconjugation Service Market Size by Region (2021-2032)
  5. 1.4.1 Global Bioconjugation Service Market Size by Region (2021-2026)
  6. 1.4.2 Global Bioconjugation Service Market Size by Region (2027-2032)
  7. 1.5 Key Regions Bioconjugation Service Market Size (2021-2032)
  8. 1.5.1 North America Bioconjugation Service Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Bioconjugation Service Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Bioconjugation Service Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Bioconjugation Service Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Bioconjugation Service Market Size Growth Rate (2021-2032)
2 Bioconjugation Service Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Protein Bioconjugation
  3. 2.1.2 Antibody Bioconjugation
  4. 2.1.3 Peptide Bioconjugation
  5. 2.1.4 Others
  6. 2.2 Global Bioconjugation Service Market Size by Type
  7. 2.2.1 Global Bioconjugation Service Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Bioconjugation Service Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Bioconjugation Service Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Bioconjugation Service Market Size by Regions
  11. 2.3.1 North America Bioconjugation Service Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Bioconjugation Service Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Bioconjugation Service Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Bioconjugation Service Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Bioconjugation Service Market Size Breakdown by Type (2021-2026)
3 Bioconjugation Service Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Pharmaceutical
  3. 3.1.2 Diagnostics
  4. 3.1.3 Biotechnology Research
  5. 3.2 Global Bioconjugation Service Market Size by Application
  6. 3.2.1 Global Bioconjugation Service Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Bioconjugation Service Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Bioconjugation Service Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Bioconjugation Service Market Size by Regions
  10. 3.3.1 North America Bioconjugation Service Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Bioconjugation Service Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Bioconjugation Service Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Bioconjugation Service Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Bioconjugation Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Bioconjugation Service Industry Trends
  2. 4.2 Bioconjugation Service Industry Drivers
  3. 4.3 Bioconjugation Service Industry Opportunities and Challenges
  4. 4.4 Bioconjugation Service Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Bioconjugation Service Revenue (2021-2026)
  2. 5.2 Global Bioconjugation Service Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Bioconjugation Service Key Company Headquarters & Area Served
  4. 5.4 Global Bioconjugation Service Company, Product Type & Application
  5. 5.5 Global Bioconjugation Service Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Bioconjugation Service Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Bioconjugation Service Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Bioconjugation Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 AxisPharm
  2. 6.1.1 AxisPharm Company Information
  3. 6.1.2 AxisPharm Business Overview
  4. 6.1.3 AxisPharm Bioconjugation Service Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 AxisPharm Bioconjugation Service Product Portfolio
  6. 6.1.5 AxisPharm Recent Developments
  7. 6.2 CellMosaic
  8. 6.2.1 CellMosaic Company Information
  9. 6.2.2 CellMosaic Business Overview
  10. 6.2.3 CellMosaic Bioconjugation Service Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 CellMosaic Bioconjugation Service Product Portfolio
  12. 6.2.5 CellMosaic Recent Developments
  13. 6.3 Bio-Synthesis
  14. 6.3.1 Bio-Synthesis Company Information
  15. 6.3.2 Bio-Synthesis Business Overview
  16. 6.3.3 Bio-Synthesis Bioconjugation Service Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Bio-Synthesis Bioconjugation Service Product Portfolio
  18. 6.3.5 Bio-Synthesis Recent Developments
  19. 6.4 GBI
  20. 6.4.1 GBI Company Information
  21. 6.4.2 GBI Business Overview
  22. 6.4.3 GBI Bioconjugation Service Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 GBI Bioconjugation Service Product Portfolio
  24. 6.4.5 GBI Recent Developments
  25. 6.5 Lonza
  26. 6.5.1 Lonza Company Information
  27. 6.5.2 Lonza Business Overview
  28. 6.5.3 Lonza Bioconjugation Service Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Lonza Bioconjugation Service Product Portfolio
  30. 6.5.5 Lonza Recent Developments
  31. 6.6 NJ Bio
  32. 6.6.1 NJ Bio Company Information
  33. 6.6.2 NJ Bio Business Overview
  34. 6.6.3 NJ Bio Bioconjugation Service Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 NJ Bio Bioconjugation Service Product Portfolio
  36. 6.6.5 NJ Bio Recent Developments
  37. 6.7 WuXi Biologics
  38. 6.7.1 WuXi Biologics Company Information
  39. 6.7.2 WuXi Biologics Business Overview
  40. 6.7.3 WuXi Biologics Bioconjugation Service Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 WuXi Biologics Bioconjugation Service Product Portfolio
  42. 6.7.5 WuXi Biologics Recent Developments
  43. 6.8 Creative Biolabs
  44. 6.8.1 Creative Biolabs Company Information
  45. 6.8.2 Creative Biolabs Business Overview
  46. 6.8.3 Creative Biolabs Bioconjugation Service Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Creative Biolabs Bioconjugation Service Product Portfolio
  48. 6.8.5 Creative Biolabs Recent Developments
  49. 6.9 Biosynth
  50. 6.9.1 Biosynth Company Information
  51. 6.9.2 Biosynth Business Overview
  52. 6.9.3 Biosynth Bioconjugation Service Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Biosynth Bioconjugation Service Product Portfolio
  54. 6.9.5 Biosynth Recent Developments
  55. 6.10 Antibody Solutions
  56. 6.10.1 Antibody Solutions Company Information
  57. 6.10.2 Antibody Solutions Business Overview
  58. 6.10.3 Antibody Solutions Bioconjugation Service Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Antibody Solutions Bioconjugation Service Product Portfolio
  60. 6.10.5 Antibody Solutions Recent Developments
  61. 6.11 CheMatech
  62. 6.11.1 CheMatech Company Information
  63. 6.11.2 CheMatech Business Overview
  64. 6.11.3 CheMatech Bioconjugation Service Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 CheMatech Bioconjugation Service Product Portfolio
  66. 6.11.5 CheMatech Recent Developments
  67. 6.12 Thermo Fisher Scientific Inc
  68. 6.12.1 Thermo Fisher Scientific Inc Company Information
  69. 6.12.2 Thermo Fisher Scientific Inc Business Overview
  70. 6.12.3 Thermo Fisher Scientific Inc Bioconjugation Service Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Thermo Fisher Scientific Inc Bioconjugation Service Product Portfolio
  72. 6.12.5 Thermo Fisher Scientific Inc Recent Developments
  73. 6.13 BOC Sciences
  74. 6.13.1 BOC Sciences Company Information
  75. 6.13.2 BOC Sciences Business Overview
  76. 6.13.3 BOC Sciences Bioconjugation Service Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 BOC Sciences Bioconjugation Service Product Portfolio
  78. 6.13.5 BOC Sciences Recent Developments
  79. 6.14 GTP Bioways
  80. 6.14.1 GTP Bioways Company Information
  81. 6.14.2 GTP Bioways Business Overview
  82. 6.14.3 GTP Bioways Bioconjugation Service Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 GTP Bioways Bioconjugation Service Product Portfolio
  84. 6.14.5 GTP Bioways Recent Developments
  85. 6.15 LifeSynth Solutions
  86. 6.15.1 LifeSynth Solutions Company Information
  87. 6.15.2 LifeSynth Solutions Business Overview
  88. 6.15.3 LifeSynth Solutions Bioconjugation Service Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 LifeSynth Solutions Bioconjugation Service Product Portfolio
  90. 6.15.5 LifeSynth Solutions Recent Developments
  91. 6.16 iQ Biosciences
  92. 6.16.1 iQ Biosciences Company Information
  93. 6.16.2 iQ Biosciences Business Overview
  94. 6.16.3 iQ Biosciences Bioconjugation Service Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 iQ Biosciences Bioconjugation Service Product Portfolio
  96. 6.16.5 iQ Biosciences Recent Developments
  97. 6.17 Macrocyclics
  98. 6.17.1 Macrocyclics Company Information
  99. 6.17.2 Macrocyclics Business Overview
  100. 6.17.3 Macrocyclics Bioconjugation Service Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Macrocyclics Bioconjugation Service Product Portfolio
  102. 6.17.5 Macrocyclics Recent Developments
  103. 6.18 piramal pharma solutions
  104. 6.18.1 piramal pharma solutions Company Information
  105. 6.18.2 piramal pharma solutions Business Overview
  106. 6.18.3 piramal pharma solutions Bioconjugation Service Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 piramal pharma solutions Bioconjugation Service Product Portfolio
  108. 6.18.5 piramal pharma solutions Recent Developments
7 North America
  1. 7.1 North America Bioconjugation Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Bioconjugation Service Market Size by Country (2021-2026)
  3. 7.3 North America Bioconjugation Service Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Bioconjugation Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Bioconjugation Service Market Size by Country (2021-2026)
  3. 8.3 Europe Bioconjugation Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Bioconjugation Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Bioconjugation Service Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Bioconjugation Service Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Bioconjugation Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Bioconjugation Service Market Size by Country (2021-2026)
  3. 10.3 South America Bioconjugation Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Bioconjugation Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Bioconjugation Service Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Bioconjugation Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst